Pharmacoeconomic research of pharmacotherapy schemes of community-acquired pneumonia with the inclusion of antiviral drugs
In the early 21st century, pneumonia remains an important medical and social problem. In Ukraine, within the structure of acute and chronic bronchopulmonary pathologies, community-acquired pneumonia (CAP) is at the forefront. According to contemporary views, the main and most common cause of CAP is...
Main Authors: | S. O. Soloviov, V. V. Trokhymchuk, I. V. Dziublyk |
---|---|
Format: | Article |
Language: | Ukrainian |
Published: |
The State Expert Center of the Ministry of Health of Ukraine
2020-03-01
|
Series: | Фармацевтичний журнал |
Subjects: | |
Online Access: | https://pharmj.org.ua/index.php/journal/article/view/816/767 |
Similar Items
-
Analysis of antiviral use efficiency criteria in the complex pharmacotherapy of community acquired pneumonia
by: S. O. Soloviov, et al.
Published: (2019-03-01) -
Conceptual foundations of pharmacoeconomic analysis of prevention technologies of chronic viral infections
by: S. O. Soloviov, et al.
Published: (2019-10-01) -
Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia
by: V. G. Deriushkin, et al.
Published: (2021-02-01) -
Pharmacoeconomic studies of technologies for prevention of hpv-associated cervical pathologies
by: S. O. Soloviov, et al.
Published: (2019-12-01) -
Pharmacoeconomics as an instrument of clinical pharmacology for optimization of pharmacotherapy
by: Reshetko O.V., et al.
Published: (2015-09-01)